|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02652 CF PHARMTECH
Nominal 
23.100 +0.940 (+4.242%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | -- | -- | 607,752 | 556,421 | 349,127 |
| Cost of Sales | -- | -- | (116,380) | (98,913) | (81,672) |
| Gross Profit | -- | -- | 491,372 | 457,508 | 267,455 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (1,328) | (612) | (1,386) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | -- | -- | (74) | (99) | 0 | |
| Profit / (Loss) before Taxation | -- | -- | 19,184 | 22,443 | (70,615) | |
| Taxation | -- | -- | 1,904 | 9,283 | 21,216 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | |
| Non-controlling Interests | -- | -- | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 2,485 | -88.216% | 21,088 | 31,726 | (49,399) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | -- | -- | 1,175 | (3,757) | (4,124) |
| Depreciation & Amortisation | -- | -- | 60,192 | 54,155 | 38,894 |
| Directors' Emoluments | -- | -- | 7,659 | 6,869 | 13,355 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 0.660 | -89.000% | 6.000 | 9.000 | -13.000 |
| DPS (cts) | 0.000 | -- | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.260 | 0.314 | 0.123 |
| NBV per share ($) | -- | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,485 |
| %Change | -88.216% |
| EPS / (LPS) | RMB 0.007 |
| NBV Per Share (¥) | RMB -- |